Get started
KRSNAA DIAGNOSTICS LTDKRSNAA DIAGNOSTICS LTDKRSNAA DIAGNOSTICS LTD

KRSNAA DIAGNOSTICS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

KRSNAA chart


Full chart

KRSNAA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪30.13 B‬ INR
Dividend yield (indicated)
0.27%
Price to earnings Ratio (TTM)
44.40
Basic EPS (TTM)
21.50 INR
Net income (FY)
‪568.37 M‬ INR
Revenue (FY)
‪6.20 B‬ INR
Shares float
‪17.70 M‬
Beta (1Y)
0.90

Employees


Employees (FY)
‪5.05 K‬
Change (1Y)
‪+2.49 K‬ +97.19%
Revenue / Employee (1Y)
‪14.70 K‬ INR
Net income / Employee (1Y)
‪1.35 K‬ INR

About KRSNAA DIAGNOSTICS LTD


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Mitesh Dave
Website
krsnaadiagnostics.com
Headquarters
Pune
ISIN
INE08LI01020
FIGI
BBG01134XRY1
Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. It offers radiology, pathology, and teleradiology services. It caters services to public and private hospitals, medical colleges and community health centers. The company was founded by Rajendra Mutha in 2011 and is headquartered in Pune, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

KRSNAA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KRSNAA is 937.00 INR — it has increased by 0.02% in the past 24 hours. Watch KRSNAA DIAGNOSTICS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange KRSNAA DIAGNOSTICS LTD stocks are traded under the ticker KRSNAA.
KRSNAA stock has risen by 5.17% compared to the previous week, the month change is a 12.63% rise, over the last year KRSNAA DIAGNOSTICS LTD has showed a 46.96% increase.
We've gathered analysts' opinions on KRSNAA DIAGNOSTICS LTD future price: according to them, KRSNAA price has a max estimate of 1,026.00 INR and a min estimate of 970.00 INR. Watch KRSNAA chart and read a more detailed KRSNAA DIAGNOSTICS LTD stock forecast: see what analysts think of KRSNAA DIAGNOSTICS LTD and suggest that you do with its stocks.
KRSNAA reached its all-time high on Aug 16, 2021 with the price of 1,099.70 INR, and its all-time low was 353.10 INR and was reached on Feb 28, 2023. View more price dynamics on KRSNAA chart.
See other stocks reaching their highest and lowest prices.
KRSNAA stock is 1.69% volatile and has beta coefficient of 0.90. Track KRSNAA DIAGNOSTICS LTD stock price on the chart and check out the list of the most volatile stocks — is KRSNAA DIAGNOSTICS LTD there?
Today KRSNAA DIAGNOSTICS LTD has the market capitalization of ‪30.13 B‬, it has increased by 3.74% over the last week.
Yes, you can track KRSNAA DIAGNOSTICS LTD financials in yearly and quarterly reports right on TradingView.
KRSNAA DIAGNOSTICS LTD is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
KRSNAA earnings for the last quarter are 6.01 INR per share, whereas the estimation was 7.60 INR resulting in a −20.92% surprise. The estimated earnings for the next quarter are 8.00 INR per share. See more details about KRSNAA DIAGNOSTICS LTD earnings.
KRSNAA DIAGNOSTICS LTD revenue for the last quarter amounts to ‪1.86 B‬ INR, despite the estimated figure of ‪1.93 B‬ INR. In the next quarter, revenue is expected to reach ‪2.01 B‬ INR.
KRSNAA net income for the last quarter is ‪195.96 M‬ INR, while the quarter before that showed ‪179.21 M‬ INR of net income which accounts for 9.35% change. Track more KRSNAA DIAGNOSTICS LTD financial stats to get the full picture.
Yes, KRSNAA dividends are paid annually. The last dividend per share was 2.50 INR. As of today, Dividend Yield (TTM)% is 0.27%. Tracking KRSNAA DIAGNOSTICS LTD dividends might help you take more informed decisions.
KRSNAA DIAGNOSTICS LTD dividend yield was 0.41% in 2023, and payout ratio reached 13.96%. The year before the numbers were 0.60% and 13.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has ‪5.05 K‬ employees. See our rating of the largest employees — is KRSNAA DIAGNOSTICS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KRSNAA DIAGNOSTICS LTD EBITDA is ‪1.73 B‬ INR, and current EBITDA margin is 23.52%. See more stats in KRSNAA DIAGNOSTICS LTD financial statements.
Like other stocks, KRSNAA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KRSNAA DIAGNOSTICS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KRSNAA DIAGNOSTICS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KRSNAA DIAGNOSTICS LTD stock shows the buy signal. See more of KRSNAA DIAGNOSTICS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.